AbbVie Inc. ( ABBV) - Key Metrics
ABBV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $9.59 | $2.04 | $1.94 | $2.09 |
| 2026Q1 | $8.46 | $0.39 | $2.16 | $2.01 |
| 2025Q4 | $9.33 | $1.02 | $2.93 | $2.75 |
| 2025Q3 | $8.90 | $0.10 | $3.96 | $4.25 |
| 2025Q2 | $8.70 | $0.53 | $2.91 | $2.76 |
ABBV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 84.83% | 30.84 |
| 2026Q1 | 441.49% | 139.42 |
| 2025Q4 | 160.30% | 56.00 |
| 2025Q3 | 1565.05% | 581.76 |
| 2025Q2 | 310.23% | 87.56 |
ABBV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.83% | 0.69% |
| 2026Q1 | 0.92% | 0.80% |
| 2025Q4 | 1.20% | 0.72% |
| 2025Q3 | 1.83% | 0.71% |
| 2025Q2 | 1.48% | 0.88% |
ABBV
Price: $264.56
Dividend Yield: 2.80%
Forward Dividend Yield: 2.61%
Payout Ratio: 207.36%
Dividend Per Share: 6.92 USD
Earnings Per Share: 3.57 USD
P/E Ratio: 68.96
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.2 million
Ebitda: 1.9 billionMarket Capitalization: 435.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 5.37%
DGR5: 7.03%
DGR10: 13.18%